Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	10.47	41.46	37.53
Graham Fair Price	0.00	0.19	0.19
PEG	inf	0.00	-0.56
Price/Book	7.69	4.25	3.95
Price/Cash Flow	7.69	42.43	39.40
Prices/Earnings	7.69	26.86	24.94
Price/Sales	7.69	2.10	1.95
Price/FCF	7.69	42.43	39.40
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.23	0.23
Operating Margin	0.00	0.03	0.03
ROA	0.00	0.01	0.01
ROE	0.04	0.04	0.00
ROIC	0.03	0.03	-8.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.28	-0.37	-23.33
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.35	0.00	inf
EPS QOQ	-0.45	0.00	inf
FCF QOQ	-0.26	0.00	inf
Revenue QOQ	-0.19	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	33.39	33.39	0.00
Days Sales Outstanding (DSO)	35.80	35.80	0.00
Inventory Turnover	2.70	2.70	0.00
Debt/Capitalization	0.34	0.39	17.11
Quick Ratio	0.46	0.46	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.20	0.20	0.00
Cash	0.04	0.04	0.00
Capex	< 0.005	< 0.005	0.00
Free Cash Flow	0.02	0.02	0.00
Revenue	0.41	0.41	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.88	0.88	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.80	4.06	44.97
Naive Interpretation	Member

06 - Financial Health · Bad

Rating